INIS
proteins
100%
genes
89%
cancer
85%
metastases
56%
tumors
45%
humans
38%
mice
37%
regulations
33%
transcription
29%
transcription factors
27%
tumor cells
26%
dna
25%
levels
20%
introns
18%
receptors
18%
control
18%
data
17%
in vitro
14%
bladder
14%
kinases
14%
carcinomas
13%
antigens
13%
migration
13%
drugs
12%
tissues
12%
adenocarcinomas
12%
apoptosis
11%
therapy
11%
in vivo
11%
melanomas
10%
patients
10%
actin
10%
phosphatases
10%
units
10%
cell cycle
9%
signals
9%
plasticity
9%
tyrosine
9%
oncogenes
9%
phenotype
9%
promoters
9%
rna
8%
methylation
8%
breasts
8%
interactions
7%
genetics
7%
nucleotides
7%
growth
7%
mutants
7%
growth factors
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
36%
Mesenchymal-Epithelial Transition
36%
Mouse
36%
Transcription
25%
ZEB2
15%
Transcription Factors
15%
Intron
14%
S100A4
14%
Binding Protein
14%
Drug Resistance
12%
Cell Motility
12%
Cadherin
11%
ZEB1
10%
Cell Migration
9%
Oncogene
8%
DNA Sequence
8%
Tumor Progression
8%
Enhancer Region
8%
Transcription Factor Fra 1
7%
Promoter Region
7%
Receptor Tyrosine Kinase
7%
C-Fos
7%
Binding Site
7%
DNA Methylation
7%
Microsatellite DNA
6%
Cell Death
6%
Epidermal Growth Factor Receptor
6%
Signal Transduction
6%
Genetics
6%
RNA
6%
Zinc Finger E Box Binding Homeobox 2
5%
Cell Survival
5%
DNA Damage
5%
Macrophage
5%
Gene Expression
5%
Keyphrases
Mts1
39%
Epithelial-mesenchymal Transition
23%
Fra-1
17%
In Cancer
15%
First Intron
15%
Activator protein-1 (AP-1)
15%
Metastasis
13%
C-Fos
12%
S100A4
12%
Nuclear factor-κB
12%
Transcriptional Repressor
11%
Tumor Cells
11%
Family Members
11%
Binding Site
10%
Actin-binding Proteins
10%
P65 Subunit
10%
ACTN4
10%
RelA
10%
Transcription Factor
9%
Fra-2
9%
Cell Motility
8%
Motility
8%
Oncogene
8%
Cancer Cells
7%
DNA Sequencing
7%
Malignant Melanoma
7%
Bladder Cancer Cells
6%
New Targets
6%
Microsatellite Markers
6%
FOS-like Antigen 1
6%
MTA1
6%
Adenocarcinoma Cells
6%
AXL Inhibitor
5%
Receptor Tyrosine Kinase
5%
Regulatory Elements
5%
Transcriptional Activity
5%
